Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Oct 15, 2024

Total Value ($000): $528,891 (100.0% shares, 0.0% debt)

Holdings (4)

CNTA CENTESSA PHARMACEUTICALS PLC 60.4%

Value ($000) $319,211 Shares 19,963,157 Est. Cost $20.88 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 25.5%

Value ($000) $134,959 Shares 7,464,572 Est. Cost $13.72 Unrealized +1.9%

NAMS NEWAMSTERDAM PHARMA COMPANY 9.0%

Value ($000) $47,635 Shares 2,869,565 Est. Cost $10.96 Unrealized +57.9%

AURA AURA BIOSCIENCES INC 5.1%

Value ($000) $27,085 Shares 3,039,892 Est. Cost $17.87 Unrealized -52.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$319,211	60.4%	$20.88	—	SPONSORED ADS	152309100
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$134,959	25.5%	$13.72	+1.9%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$47,635	9.0%	$10.96	+57.9%	ORDINARY SHARES	N62509109
AURA	AURA BIOSCIENCES INC	3,039,892	$27,085	5.1%	$17.87	-52.0%	COM	05153U107